Emergence of the colistin resistance mcr-1 determinant in commensal Escherichia coli from residents of long-term-care facilities in Italy

J Antimicrob Chemother. 2016 Aug;71(8):2329-31. doi: 10.1093/jac/dkw195. Epub 2016 Jun 3.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Anti-Bacterial Agents / adverse effects
  • Anti-Bacterial Agents / pharmacology*
  • Anti-Bacterial Agents / therapeutic use
  • Colistin / adverse effects
  • Colistin / pharmacology*
  • Colistin / therapeutic use
  • Drug Resistance, Bacterial / genetics
  • Escherichia coli / drug effects*
  • Escherichia coli / genetics
  • Escherichia coli / isolation & purification*
  • Escherichia coli Infections / epidemiology
  • Escherichia coli Infections / microbiology
  • Escherichia coli Infections / transmission
  • Escherichia coli Proteins / genetics*
  • Escherichia coli Proteins / isolation & purification
  • Female
  • Humans
  • Italy / epidemiology
  • Long-Term Care
  • Male
  • Symbiosis

Substances

  • Anti-Bacterial Agents
  • Escherichia coli Proteins
  • MCR-1 protein, E coli
  • Colistin